Wells Fargo & Co began coverage on shares of Phreesia (NYSE:PHR) in a research note released on Monday, BenzingaRatingsTable reports. The firm issued an outperform rating and a $23.00 price objective on the stock.
Several other research analysts also recently weighed in on PHR. Chardan Capital initiated coverage on Phreesia in a research note on Tuesday, July 23rd. They issued a buy rating and a $33.00 price target for the company. William Blair initiated coverage on Phreesia in a research note on Monday. They issued an outperform rating for the company. Finally, Piper Jaffray Companies initiated coverage on Phreesia in a research note on Monday. They issued an overweight rating and a $33.00 price target for the company. Five investment analysts have rated the stock with a buy rating, The stock presently has an average rating of Buy and an average price target of $30.50.
PHR stock opened at $26.34 on Monday. Phreesia has a 1-year low of $23.00 and a 1-year high of $29.38.
Phreesia Company Profile
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments.
Recommended Story: What is Considered a Good Return on Equity (ROE)?
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.